About Unravel Biosciences
Unravel Biosciences is a private company based in Medford, Massachusetts. It has reported $5,100,000 raised in three offerings on Form D since August 2021. Its chief executive is Richard Novak.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | Aug 24, 2026 | $4,100,000of $4.5M target | 2 | $2.0M | Debt, OptionsRule 506(b) | Form D ↗ |
| Feb 22, 2023 | Mar 9, 2023 | $500,000of $2.0M target | 4 | $125K | Equity, OptionsRule 506(b) | Form D ↗ |
| Jul 23, 2021 | Aug 6, 2021 | $500,000of $1.0M target | 3 | $166K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $5,100,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Unravel Biosciences's Form D filed Aug 24, 2026.
Earlier filings also listed Lewis Geffen (secretary, last listed Aug 2021).